Development of Upper Aerodigestive Tract Splint

Sponsor
University Health Network, Toronto (Other)
Overall Status
Recruiting
CT.gov ID
NCT04544800
Collaborator
(none)
30
1
1
72
0.4

Study Details

Study Description

Brief Summary

The study hypothesis is that a splint will improve access to the upper aerodigestive tract (UADT) for diagnosis and treatment.

Condition or Disease Intervention/Treatment Phase
  • Device: Use of Splint for UADT Visualization
N/A

Detailed Description

This is a pilot study of 30 patients. We will tabulate the data for efficacy, there will be no statistical analysis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Development of Upper Aerodigestive Tract Splint
Actual Study Start Date :
May 31, 2018
Anticipated Primary Completion Date :
May 31, 2023
Anticipated Study Completion Date :
May 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Use of Splint for UADT Visualization

Use of device to view UADT

Device: Use of Splint for UADT Visualization
The use of a splint to assist the patient and the surgeon with UADT procedures.

Outcome Measures

Primary Outcome Measures

  1. Patient Splint Satisfaction Questionnaire [Immediately after the intervention/procedure/surgery]

    Self-administered, 6-item questionnaire to evaluate splint satisfaction.

  2. Physician Splint Satisfaction Questionnaire [Immediately after the intervention/procedure/surgery]

    A 14-item questionnaire to evaluate the surgeon satisfaction with the splint.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Require a procedure involving the upper aerodigestive tract (UADT)
Exclusion Criteria:
  • Prior surgery to tongue or mouth that precludes the use of the splint

  • Trismus with mouth opening that does not allow for use of the splint

  • TMJ dysfunction that precludes the use of the splint

  • Allergy to local anesthetic

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Health Network Toronto Ontario Canada M5G 2C4

Sponsors and Collaborators

  • University Health Network, Toronto

Investigators

  • Principal Investigator: Douglas B Chepeha, MD, University Health Network, Toronto

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT04544800
Other Study ID Numbers:
  • 17-5577
First Posted:
Sep 10, 2020
Last Update Posted:
Apr 27, 2022
Last Verified:
Apr 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Health Network, Toronto

Study Results

No Results Posted as of Apr 27, 2022